NCT01590160View on ClinicalTrials.gov

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 5, 2019

Study Completion Date

November 5, 2019

Conditions
Lung Cancer - Malignant Pleural Mesothelioma
Interventions
DRUG

Ganetespib

IV, Using dose from Phase I

Trial Locations (1)

W1T 4TJ

UCL Cancer Trials Centre, London

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER